| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |